Palforzia Market Report 2026

Palforzia Market Overview

• The Palforzia market growth in the historic period has been driven by increasing prevalence of peanut allergies, improved diagnosis of food hypersensitivities • Market expansion is supported by growing adoption of disease-modifying allergy treatments, expansion of food allergy management programs • Growth Driver: Rising Prevalence Of Allergies Fuels Growth In The Market • Market Trend: Advancements In Peanut Allergy Treatment With Oral Immunotherapy • North America was the largest region in 2025.

What Is Covered Under Palforzia Market?

Palforzia is an oral immunotherapy (OIT) medication designed to help reduce the severity of allergic reactions, including anaphylaxis, in individuals with a confirmed peanut allergy. It is specifically approved for use in children and adolescents aged 4 through 17, though it may be continued in older patients under medical supervision. The main types of clinical indications for palforzia include peanut allergy treatment, maintenance phase of oral immunotherapy (OIT), and peanut allergy with a risk of severe reactions. Peanut allergy treatment typically involves avoiding peanuts and managing symptoms through emergency medications for severe reactions. The distribution channels include retail pharmacies, specialty pharmacies, healthcare facilities for end users, such as hospitals, clinics, ambulatory care, and home care.

What Is The Palforzia Market Growth Forecast?

The growth in the forecast period can be attributed to growing adoption of disease-modifying allergy treatments, expansion of food allergy management programs, rising investments in immunotherapy innovation, broader regulatory approvals for OIT products, increasing demand for long-term allergy risk reduction. Major trends in the forecast period include increasing adoption of oral immunotherapy for food allergies, increasing focus on pediatric allergy treatments, expansion of structured desensitization protocols, rising demand for preventive anaphylaxis therapies, enhanced monitoring of treatment safety.

Global Palforzia Market Segmentation

1) By Clinical Indication: Peanut Allergy Treatment, Maintenance Phase Of Oral Immunotherapy (OIT), Peanut Allergy With a Risk Of Severe Reactions 2) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Healthcare Facilities 3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Is The Driver Of The Palforzia Market?

The increasing prevalence of allergies is expected to propel the growth of the palforiza market going forward. Allergy refers to an abnormal immune response to substances (allergens) that are usually harmless, such as pollen, dust, or certain foods, triggering symptoms like sneezing, rashes, or even severe reactions like anaphylaxis. The prevalence of allergies is rising, driven by factors such as environmental changes, pollution, genetic predisposition, and lifestyle factors like diet, hygiene, and increased exposure to allergens. Palforzia is used for oral immunotherapy to treat peanut allergies by gradually desensitizing the immune system to peanut proteins, helping reduce the severity of allergic reactions, including anaphylaxis, caused by accidental exposure to peanuts. For instance, in August 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, the number of hospital admissions of individuals having allergies and anaphylaxis increased to 32,300 in 2023-24 compared to 25,702 in 2022-23. Therefore, the increasing prevalence of peanut allergies is driving the palforiza market.

Key Players In The Global Palforzia Market

Major companies operating in the palforzia market are Stallergenes Greer International AG

Global Palforzia Market Trends and Insights

Major companies operating in the Palforzia market are focusing on developing innovative solutions, such as FDA-approved oral immunotherapy (OIT) treatments, to meet the rising demand for safer, more effective, and clinically validated options for managing peanut allergies. Oral immunotherapy involves administering controlled, gradually increasing doses of an allergen to desensitize the immune system, offering a structured and long-term treatment approach compared with traditional avoidance-based management that does not modify the underlying immune response. For instance, in July 2024, Stallergenes Greer, a Switzerland-based company, received Food and Drug Administration (FDA) approval for the extension of the pediatric indication for Palforzia (peanut (Arachis hypogaea) protein) oral immunotherapy, providing allergy immunotherapy solutions globally. It features a gradual dose escalation process to desensitize individuals with peanut allergies, and it is available in powder form for oral administration, with different dosage levels tailored to the patient's tolerance.

What Are Latest Mergers And Acquisitions In The Palforzia Market?

In September 2023, Stallergenes Greer, a Switzerland-based company that provides immunotherapy treatments, acquired Palforzia from Nestle SA for an undisclosed amount. With this acquisition, Stallergenes Greer aims to strengthen its allergy treatment portfolio and expand into food allergy therapies. Nestlé SA is a Switzerland-based company that provides food, beverages, nutrition, health science, and pet care products, including developing palforzia for allergy treatment.

Regional Insights

North America was the largest region in the palforzia market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Palforzia Market?

The palforzia market consists of sales of products such as pre-measured oral capsules and powder sachets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Palforzia Market Report 2026?

The palforzia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the palforzia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.